stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / VCYT / Revenue

Veracyte, Inc. Revenue 2011–2025

Veracyte, Inc. (VCYT) annual revenue by fiscal year, computed from SEC filings. Compound growth +45.8%/yr over 14 years.

Fiscal yearRevenueChange (YoY)
FY 2025$517.14M+16.0%
FY 2024$445.76M+23.5%
FY 2023$361.05M+21.8%
FY 2022$296.54M+35.1%
FY 2021$219.51M+86.8%
FY 2020$117.48M-2.4%
FY 2019$120.37M+30.8%
FY 2018$92.01M+27.9%
FY 2017$71.95M+10.6%
FY 2016$65.08M+31.5%
FY 2015$49.50M+29.6%
FY 2014$38.19M+74.5%
FY 2013$21.88M+88.2%
FY 2012$11.63M+339.6%
FY 2011$2.65M

Source: Veracyte, Inc. SEC filings — income statement (10-K). Refreshed nightly.

See the full picture for Veracyte, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Veracyte, Inc. — frequently asked questions

What is Veracyte, Inc.'s revenue?

Veracyte, Inc. (VCYT) reported revenue of $517.14M for fiscal year 2025, per its SEC filings.

How has Veracyte, Inc.'s revenue changed over time?

Between fiscal 2011 and 2025, VCYT's revenue grew at roughly 45.8% per year (compound annual rate), from $2.65M to $517.14M.

Where does this data come from?

Figures are computed from Veracyte, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More VCYT financial history

Full VCYT fundamentals page → · All 1,500+ companies →